Mogrify

Structure of the eye
#Mogrify #Preclinical development #Retinal diseases #Transcriptomics

MOGRIFY-derived transcription factors preserve functional vision

Mogrify will present preclinical proof-of-concept data at FLORetina-ICOOR 2026 in support its first-in-class therapy designed to protect and regenerate the retina in patients with retinal disorders.  The company’s lead programme uses transcription factor-mediated direct reprogramming to convert müller glial cells into functional photoreceptors within the retina.  … Read More

#News